NCT03145844View on ClinicalTrials.gov

Direct Acting Agents in Hepatitis C Patients

CompletedOBSERVATIONAL
Enrollment

2,700

Participants

Timeline

Start Date

April 9, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Hepatitis CHepatitis C RelapseHepatitis C Recurrent
Trial Locations (1)

Unknown

Cerrahpasa Medical Faculty, Istanbul

All Listed Sponsors
collaborator

Viral Hepatitis Society

OTHER

lead

Fehmi Tabak

OTHER

NCT03145844 - Direct Acting Agents in Hepatitis C Patients | Biotech Hunter | Biotech Hunter